Triangle Securities Wealth Management Amgen Inc Transaction History

Triangle Securities Wealth Management

$377 Million
Q3 2024

A detailed history of Triangle Securities Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Triangle Securities Wealth Management holds 7,033 shares of AMGN stock, worth $2.07 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

7,033

Previous 7,232 2.75%

Holding current value

$2.07 Million

Previous $2.26 Million 0.31%

% of portfolio

0.6%

Previous 0.65%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $61,566 - $67,138	-199 Reduced 2.75%	7,033 $2.27 Million
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $10,510 - $12,772	-40 Reduced 0.55%	7,232 $2.26 Million
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $44,632 - $53,876	-166 Reduced 2.23%	7,272 $2.07 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $11,506 - $12,980	-45 Reduced 0.6%	7,438 $2.14 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $12,681 - $15,744	-58 Reduced 0.77%	7,483 $2.01 Million
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $12,213 - $14,442	57 Added 0.76%	7,541 $1.67 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $38,610 - $47,059	-171 Reduced 2.23%	7,484 $1.81 Million
Q4 2022 Jan 11, 2023	SELL	$229.03 - $291.01 $95,276 - $121,060	-416 Reduced 5.15%	7,655 $0
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $48,932 - $55,186	-218 Reduced 2.63%	8,071 $1.82 Million
Q2 2022 Jul 11, 2022	SELL	$230.71 - $256.74 $17,072 - $18,998	-74 Reduced 0.88%	8,289 $2.02 Million
Q1 2022 Apr 13, 2022	SELL	$219.27 - $242.57 $73,455 - $81,260	-335 Reduced 3.85%	8,363 $2.02 Million
Q4 2021 Jan 14, 2022	SELL	$198.88 - $227.6 $16,904 - $19,346	-85 Reduced 0.97%	8,698 $1.96 Million
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $18,892 - $22,134	-89 Reduced 1.0%	8,783 $1.87 Million
Q2 2021 Jul 12, 2021	SELL	$233.58 - $259.14 $43,679 - $48,459	-187 Reduced 2.06%	8,872 $2.16 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $19,306 - $22,498	87 Added 0.97%	9,059 $2.25 Million
Q4 2020 Jan 11, 2021	SELL	$216.38 - $257.67 $87,633 - $104,356	-405 Reduced 4.32%	8,972 $2.06 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $61,712 - $68,629	-263 Reduced 2.73%	9,377 $2.38 Million
Q2 2020 Jul 08, 2020	SELL	$197.81 - $242.74 $204,733 - $251,235	-1,035 Reduced 9.7%	9,640 $2.27 Million
Q1 2020 Apr 06, 2020	SELL	$182.24 - $241.7 $95,676 - $126,892	-525 Reduced 4.69%	10,675 $2.16 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $34,436 - $44,262	-182 Reduced 1.6%	11,200 $2.7 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $20,893 - $25,034	-120 Reduced 1.04%	11,382 $2.2 Million
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $14,169 - $16,609	85 Added 0.74%	11,502 $2.1 Million
Q1 2019 Apr 08, 2019	SELL	$180.87 - $203.88 $47,930 - $54,028	-265 Reduced 2.27%	11,417 $2.17 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $16,056 - $18,742	-90 Reduced 0.76%	11,682 $2.27 Million
Q3 2018 Oct 04, 2018	SELL	$185.29 - $208.89 $43,357 - $48,880	-234 Reduced 1.95%	11,772 $2.44 Million
Q2 2018 Jul 12, 2018	SELL	$166.05 - $186.51 $27,398 - $30,774	-165 Reduced 1.36%	12,006 $2.22 Million
Q1 2018 Apr 11, 2018	BUY	$169.43 - $198.0 $74,718 - $87,318	441 Added 3.76%	12,171 $2.08 Million
Q4 2017 Jan 10, 2018	SELL	$168.79 - $188.59 $27,681 - $30,928	-164 Reduced 1.38%	11,730 $2.04 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $1.99 Million - $2.27 Million	11,894	11,894 $2.22 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triangle Securities Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Triangle Securities Wealth Management with notifications on news.

Account

Triangle Securities Wealth Management Amgen Inc Transaction History